Dividend 15 Split Corp. (TSX:DFN.PR.A) Completes Preferred Shares Offering

TORONTO, January 16, 2026 — Leads & Copy — Dividend 15 Split Corp. has announced the completion of its overnight marketing of Preferred Shares (TSX: DFN.PR.A), with total gross proceeds expected to be approximately $142.6 million.

The offering was led by National Bank Financial Inc., and the sales period has now ended. The offering is expected to close on or about January 23, 2026, pending TSX approval and other closing conditions.

The Preferred Shares are being offered at $10.45 each. The closing price on the TSX of the Preferred Shares on January 15, 2026, was $10.53.

The Company intends to use the net proceeds to invest in an actively managed portfolio of dividend-yielding Canadian companies, including:

Bank of Montreal
Enbridge Inc.
TC Energy
The Bank of Nova Scotia
Manulife Financial Corp.
TELUS Corporation
BCE Inc.
National Bank of Canada
Thomson Reuters Corp.
Canadian Imperial Bank of Commerce
Royal Bank of Canada
The Toronto-Dominion Bank
Sun Life Financial Inc.
TransAlta Corporation

Dividend 15 Split Corp.’s Preferred Share investment objectives include providing holders with fixed, cumulative preferential monthly cash dividends of 7.00% annually, based on the original $10 issue price. The objective also includes paying holders the original $10 issue price on or about the termination date, currently December 1, 2029, which is subject to further 5-year extensions.

A prospectus supplement to the Company’s short form base shelf prospectus dated September 6, 2024, as amended November 21, 2025, containing detailed information about the Preferred Shares and the Class A Shares being offered, will be filed with securities commissions in all provinces of Canada. Copies of the prospectus supplement and the short form base shelf prospectus can be obtained from registered financial advisors or from representatives of the agents listed above. No sale or acceptance of an offer to buy the securities will occur until the prospectus supplement has been filed.

For further information, please contact Dividend 15 Split Corp. Investor Relations at 416-304-4443 or toll-free at 1-877-4-Quadra (1-877-478-2372).

Contact: Dividend 15 Split Corp. Investor Relations, 416-304-4443, 1-877-4-Quadra (1-877-478-2372)

Source: Dividend 15 Split Corp.

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.